N-[(2S,3S,4R)-3,4-dihydroxy-14-phenyl-1-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]hexacosanamide

C52H95NO9 — CID 153423637

IUPACN-[(2S,3S,4R)-3,4-dihydroxy-14-phenyl-1-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]hexacosanamide
SMILESCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@H]1OC(CO)[C@H](O)[C@H](O)C1O)[C@H](O)[C@H](O)CCCCCCCCCCc1ccccc1
InChIInChI=1S/C52H95NO9/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-26-29-35-40-47(56)53-44(42-61-52-51(60)50(59)49(58)46(41-54)62-52)48(57)45(55)39-34-28-25-23-22-24-27-31-36-43-37-32-30-33-38-43/h30,32-33,37-38,44-46,48-52,54-55,57-60H,2-29,31,34-36,39-42H2,1H3,(H,53,56)/t44-,45+,46?,48-,49-,50-,51?,52-/m0/s1
InChIKeyQDUCOKDHQCOICH-ACPWGHHISA-N
MW878.33 g/mol
LogP10.15
Rot. Bonds42

About N-[(2S,3S,4R)-3,4-dihydroxy-14-phenyl-1-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]hexacosanamide

N-[(2S,3S,4R)-3,4-dihydroxy-14-phenyl-1-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]hexacosanamide (PubChem CID 153423637) has the molecular formula C52H95NO9 and a molecular weight of 878.33 g/mol. Its IUPAC name is N-[(2S,3S,4R)-3,4-dihydroxy-14-phenyl-1-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]hexacosanamide.

Molecular Properties

Compound NameN-[(2S,3S,4R)-3,4-dihydroxy-14-phenyl-1-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]hexacosanamide
PubChem CID153423637
Molecular FormulaC52H95NO9
Molecular Weight878.33 g/mol
Exact Mass877.70
IUPAC NameN-[(2S,3S,4R)-3,4-dihydroxy-14-phenyl-1-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]hexacosanamide
SMILESCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@H]1OC(CO)[C@H](O)[C@H](O)C1O)[C@H](O)[C@H](O)CCCCCCCCCCc1ccccc1
InChIInChI=1S/C52H95NO9/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-26-29-35-40-47(56)53-44(42-61-52-51(60)50(59)49(58)46(41-54)62-52)48(57)45(55)39-34-28-25-23-22-24-27-31-36-43-37-32-30-33-38-43/h30,32-33,37-38,44-46,48-52,54-55,57-60H,2-29,31,34-36,39-42H2,1H3,(H,53,56)/t44-,45+,46?,48-,49-,50-,51?,52-/m0/s1
InChIKeyQDUCOKDHQCOICH-ACPWGHHISA-N
XLogP10.15
TPSA168.94 Ų
H-Bond Donors7
H-Bond Acceptors9
Rotatable Bonds42
Heavy Atoms62
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500878.33
LogP ≤ 510.15
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[(2S,3S,4R)-3,4-dihydroxy-14-phenyl-1-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]hexacosanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(2S,3S,4R)-3,4-dihydroxy-14-phenyl-1-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]hexacosanamide?
The IUPAC name of N-[(2S,3S,4R)-3,4-dihydroxy-14-phenyl-1-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]hexacosanamide (CID 153423637) is N-[(2S,3S,4R)-3,4-dihydroxy-14-phenyl-1-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]hexacosanamide.
What is the SMILES notation for N-[(2S,3S,4R)-3,4-dihydroxy-14-phenyl-1-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]hexacosanamide?
The canonical SMILES for N-[(2S,3S,4R)-3,4-dihydroxy-14-phenyl-1-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]hexacosanamide is CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@H]1OC(CO)[C@H](O)[C@H](O)C1O)[C@H](O)[C@H](O)CCCCCCCCCCc1ccccc1.
What is the InChIKey of N-[(2S,3S,4R)-3,4-dihydroxy-14-phenyl-1-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]hexacosanamide?
The InChIKey is QDUCOKDHQCOICH-ACPWGHHISA-N. The full InChI is InChI=1S/C52H95NO9/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-26-29-35-40-47(56)53-44(42-61-52-51(60)50(59)49(58)46(41-54)62-52)48(57)45(55)39-34-28-25-23-22-24-27-31-36-43-37-32-30-33-38-43/h30,32-33,37-38,44-46,48-52,54-55,57-60H,2-29,31,34-36,39-42H2,1H3,(H,53,56)/t44-,45+,46?,48-,49-,50-,51?,52-/m0/s1.
What are the key properties of N-[(2S,3S,4R)-3,4-dihydroxy-14-phenyl-1-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]hexacosanamide?
N-[(2S,3S,4R)-3,4-dihydroxy-14-phenyl-1-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]hexacosanamide has a molecular weight of 878.33 g/mol, XLogP of 10.15, 42 rotatable bonds, 7 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(2S,3S,4R)-3,4-dihydroxy-14-phenyl-1-[(2S,4S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytetradecan-2-yl]hexacosanamide is sourced from PubChem (CID 153423637), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).